Yvonne Yamanaka

Yvonne Yamanaka, Ph.D., is a Principal at venBio Partners with a background in biological engineering and life science company creation. Prior to joining venBio, Yvonne was a member of the venture creation team at Flagship Pioneering. She began her research career leading the development of a novel immunotherapy technology at EMD/Merck Serono. Yvonne received her Ph.D. in Biological Engineering from MIT, where she was a Siebel Scholar and NSF Graduate Research Fellow, and her B.S.E. in Biomedical Engineering from Duke University, where she was an Angier B. Duke and Goldwater scholar.